PRESENTATION

Q3 FY2023 — Presentation

Q3 FY2023PDF · 24 pages1.4 MB
Lam Research
Corporation
March quarter 2023 financial results
April 19, 2023

-- 1 of 24 --

L A M R E S E A R C H
Confidential – Limited Access and Use
Cautionary statement regarding forward-looking
statements
This presentation and the accompanying discussion contain “forward-looking statements” under U.S. securities laws. Forward-looking
statements include any statements that are not statements of historical fact. Examples of forward-looking statements include, but are not
limited to: (1) anticipated business, balance sheet, cash flow and financial measures and results, including guidance, whether on a GAAP or
non-GAAP basis; (2) economic, market, industry and industry segment expectations; (3) product performance and changes in market share or
customer demands; (4) our ability to successfully execute business, capital allocation, product and growth plans or strategies, or otherwise
deliver value for customers and stockholders; (5) the impact and expected duration of supply chain disruptions, and our ability to mitigate
them; (6) the impact of the COVID-19 pandemic on our operations and financial results, and our ability to mitigate operational and business
impacts caused by it; and (7) the impact of trade regulations, export controls and trade disputes. Forward-looking statements speak only as of
the date they are made and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed,
including: trade regulations, export controls, trade disputes and other geopolitical tensions may inhibit our ability to sell our products;
business, political and/or regulatory conditions in the consumer electronics industry, the semiconductor industry and the overall economy may
deteriorate or change; the actions of our customers and competitors may be inconsistent with our expectations; supply chain cost increases
and other inflationary pressures have impacted and are expected to continue to impact our profitability; supply chain disruptions or
manufacturing capacity constraints may limit our ability to manufacture and sell our products; the severity, magnitude and duration of the
COVID–19 pandemic (and the related governmental, public health, business and community responses to it), and their impacts on our
business, results of operations and financial condition, are evolving and are highly uncertain and unpredictable; and widespread outbreaks of
illness may impact our operations and revenue in affected areas; as well as the other factors discussed in our filings with the Securities and
Exchange Commission (“SEC”), including specifically the Risk Factors described in our annual report on Form 10–K for the fiscal year ended
June 26, 2022 and our quarterly report on Form 10-Q for the quarter ended December 25, 2022. You should not place undue reliance on
forward-looking statements. Lam undertakes no obligation to update any forward-looking statements.

-- 2 of 24 --

L A M R E S E A R C H
Confidential – Limited Access and Use
$1.7B
R&D*
~18,700
EMPLOYEES
A s of Marc h 26, 2023
$19.0B
REVENUE*
10 PRIMARY LOCATIONS
+ Fremont, CA
+ Livermore, CA
+ Sherwood, OR
+ Tualatin, OR
+ Springfield, OH
+ Eaton, OH
+ Villach, Austria
+ Gyeonggi-do, Korea
+ Taoyuan City, Taiwan
+ Batu Kawan, Malaysia
AWARDS AND RECOGNITION
100 Most Sustainable U.S. Companies
Barron’s
World’s Most Ethical Companies
Ethisphere
America’s Best Employers for Diversity
Forbes
World’s Most Admired Companies
Fortune
Best Places to Work For LGBTQ+ Equality
Human Rights Campaign
Dow Jones Sustainability Index
North America
S&P Global
A global leader in wafer
fabrication equipment
and services since 1980
*Figures as of calendar year 2022

-- 3 of 24 --

L A M R E S E A R C H
Business review &
industry outlook
Tim Archer
President and Chief Executive Officer

-- 4 of 24 --

L A M R E S E A R C H
Confidential – Limited Access and Use
March quarter
performance
Revenue of $3.87B and EPS of $6.99 exceed
midpoint of guidance range
Record quarter of Foundry systems
revenue with solid progress in leading-edge
& specialty technology segments
Investing in long-term technology
roadmaps while managing spending and
strengthening operational processes
EPS = earnings per share
EPS calculated on a non-GAAP basis. Reconciliations of U.S GAAP results to non-GAAP results can be found at the end of this presentation.

-- 5 of 24 --

L A M R E S E A R C H
Confidential – Limited Access and Use
WFE outlook
CY 2023 WFE expected to be in the low to mid $70B range
Additional weakness from memory customers, partially offset by
domestic China-related demand across logic and memory
• Memory customers limiting bit output to drive down elevated inventory
• Expect memory spending down approximately 50% from 2022 led by NAND
Current memory spending unsustainable to support long-term NAND
and DRAM bit demand growth
Memory leadership position and large installed base provide valuable
platform for growth when customers ramp to normal levels
WFE = wafer fabrication equipment
CY = calendar year

-- 6 of 24 --

L A M R E S E A R C H
Confidential – Limited Access and Use
Rising complexity fundamental to Lam’s opportunity
Lam has a leading share position with a broadening
product footprint as EUV adoption scales
Our etch and deposition solutions enhance
productivity by creating smooth patterns and
reducing line width roughness
Lam’s dry resist technologies gaining momentum
with multiple customer adoptions
Patterning with EUV
EUV = extreme ultraviolet

-- 7 of 24 --

L A M R E S E A R C H
Confidential – Limited Access and Use
Rising complexity fundamental to Lam’s opportunity
Complex 3D architecture plays to Lam’s strengths
Close to one-billion-dollar incremental opportunity
Lam’s ALD/ALE capabilities, including Argos®,
Prevos®, and Selis® selective etch tools and
ALD low k spacer and nitride films, are winning
at multiple customers
Gate-all-around
ALD = atomic layer deposition
ALE = atomic layer etching

-- 8 of 24 --

L A M R E S E A R C H
Near-term focus on expenses
and operations
Prioritization of R&D investments tied
to critical manufacturing inflections
Installed base has grown ~40%
since last downturn
Strong position to outperform
when WFE growth resumes
Positioned for long-term outperformance

-- 9 of 24 --

L A M R E S E A R C H
Confidential – Limited Access and Use
March quarter 2023
financial results &
June quarter 2023 outlook
Doug Bettinger
Executive Vice President and Chief Financial Officer

-- 10 of 24 --

L A M R E S E A R C H
Confidential – Limited Access and Use
QMAR’23 REVENUE
QMAR’23 DEFERRED REVENUE*
March quarter highlights
$3.87B
QDec'22 revenue: $5.28B
$2.0B
QDec'22 deferred revenue: $2.0B
*Lam’s deferred revenue balance does not include shipments to customers in Japan, to whom title does not transfer until customer acceptance.
Estimated future revenue from shipments to customers in Japan was approximately $212M as of March 26, 2023 and $379M as of December 25, 2022.

-- 11 of 24 --

L A M R E S E A R C H
Confidential – Limited Access and Use
China
22%
Korea
22%
Taiwan
18%
US
16%
Japan
10%
Europe
8%
SEA
4%
REVENUE BY REGION
March quarter revenue mix
NVM
23%
DRAM
9%
Foundry
46%
Logic/other
22%
System revenue segments*
Memory
32%
Record level of Foundry revenue dollars
NVM = Non-Volatile Memory
*Systems revenue includes equipment and equipment upgrade sales from etch, deposition, clean, and our Reliant® product line

-- 12 of 24 --

L A M R E S E A R C H
Confidential – Limited Access and Use
QMAR’23 CSBG REVENUE
Customer Support Business Group
$1.61B
QDec'22 CSBG revenue: $1.73B
QMar'22 CSBG revenue: $1.41B

-- 13 of 24 --

L A M R E S E A R C H
Confidential – Limited Access and Use
QMAR'23 QDEC'22
Revenue $3,870M $5,278M
Non-GAAP gross margin* 44.0% 45.1%
Non-GAAP operating expenses* $608M $686M
Non-GAAP operating income* $1,097M $1,695M
Non-GAAP operating income as a percentage of revenue* 28.3% 32.1%
Non-GAAP other expense, net* $8M $38M
U.S. GAAP diluted EPS $6.01 $10.77
Non-GAAP diluted EPS* $6.99 $10.71
Diluted share count 135M 136M
March quarter financial results
*A reconciliation of U.S. GAAP results to non-GAAP results can be found at the end of this presentation.

-- 14 of 24 --

L A M R E S E A R C H
Confidential – Limited Access and Use
Key balance sheet and financial metrics
QMAR'23 QDEC'22
Total consolidated gross cash balance $5,620M $4,839M
Account receivables, net $3,262M $4,070M
DSO 77 days 70 days
Inventories $4,882M $4,820M
Inventory turns 1.9 2.4
Deferred revenue* $2,003M $1,984M
Capital expenditures $119M $163M
Equity compensation expense $74M $73M
Amortization expense $14M $12M
Depreciation expense $78M $73M
Share repurchases $483M $483M
Cash dividends $234M $236M
Headcount ~18,700 ~19,200
*Lam’s deferred revenue balance does not include shipments to customers in Japan, to whom title does not transfer until customer acceptance.
Estimated future revenue from shipments to customers in Japan was approximately $212M as of March 26, 2023 and $379M as of December 25, 2022.

-- 15 of 24 --

L A M R E S E A R C H
Confidential – Limited Access and Use
$3.1B +/- $300M
Revenue
44.0% +/- 1%
Non-GAAP gross margin*
25.5% +/- 1%
Non-GAAP operating margin*
$5.00 +/- $0.75
Non-GAAP earnings per share*
June 2023
quarter guidance
A reconciliation of U.S. GAAP projected results to non-GAAP projected results can be found at the end of this presentation.
*Based on a diluted share count of approximately 134 million shares.

-- 16 of 24 --

L A M R E S E A R C H
Confidential – Limited Access and Use
Q&A

-- 17 of 24 --

L A M R E S E A R C H
Confidential – Limited Access and Use
Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income
(in thousands, except per share data)
(unaudited)
Three Months Ended
March 26,
2023
December 25,
2022
U.S. GAAP net income $ 814,008 $ 1,468,507
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations - cost of goods sold 3,093 2,521
Elective deferred compensation ("EDC") related liability valuation increase - cost of goods sold 1,498 2,853
Restructuring charges, net - cost of goods sold 66,720 —
Product rationalization - cost of goods sold 26,842 —
Transformational costs - cost of goods sold 558 —
EDC related liability valuation increase - research and development 2,697 5,136
Product rationalization - research and development 3,858 —
Amortization related to intangible assets acquired through certain business combinations - selling, general and administrative 1,395 1,279
EDC related liability valuation increase - selling, general and administrative 1,798 3,424
Product rationalization - selling, general and administrative 2,891 —
Transformational costs - selling, general and administrative 2,692 —
Restructuring charges, net – operating expenses 40,408 —
Amortization of note discounts - other income (expense), net 718 712
Gain on EDC related asset - other income (expense), net (5,443) (10,871)
Net income tax benefit on non-GAAP items (17,250) (1,213)
Net income tax benefit associated with legal entity restructuring — (11,773)
Non-GAAP net income $ 946,483 $ 1,460,575
Non-GAAP net income per diluted share $ 6.99 $ 10.71
U.S. GAAP net income per diluted share $ 6.01 $ 10.77
U.S. GAAP and non-GAAP number of shares used for per diluted share calculation 135,395 136,339
Appendix – reconciliation

-- 18 of 24 --

L A M R E S E A R C H
Confidential – Limited Access and Use
Three Months Ended
March 26,
2023
December 25,
2022
U.S. GAAP gross margin $ 1,605,612 $ 2,376,349
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations 3,093 2,521
EDC related liability valuation increase 1,498 2,853
Restructuring charges, net 66,720 —
Product rationalization 26,842 —
Transformational costs 558 —
Non-GAAP gross margin $ 1,704,323 $ 2,381,723
U.S. GAAP gross margin as a percentage of revenue 41.5 % 45.0 %
Non-GAAP gross margin as a percentage of revenue 44.0 % 45.1 %
U.S. GAAP operating expenses $ 663,359 $ 696,187
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations (1,395) (1,279)
EDC related liability valuation increase (4,495) (8,560)
Restructuring charges, net (40,408) —
Product rationalization (6,749) —
Transformational costs (2,692) —
Non-GAAP operating expenses $ 607,620 $ 686,348
U.S. GAAP operating income $ 942,253 $ 1,680,162
Non-GAAP operating income $ 1,096,703 $ 1,695,375
U.S. GAAP operating income as percent of revenue 24.4 % 31.8 %
Non-GAAP operating income as a percent of revenue 28.3 % 32.1 %
Appendix – reconciliation
Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income to Non-GAAP Gross Margin, Operating Expenses and Operating Income
(in thousands, except percentages)
(unaudited)

-- 19 of 24 --

L A M R E S E A R C H
Confidential – Limited Access and Use
Three Months Ended
March 26,
2023
December 25,
2022
U.S. GAAP Other income (expense), net $ (3,331) $ (28,234)
Pre-tax non-GAAP items:
Amortization of note discounts 718 712
Gain on EDC related asset (5,443) (10,871)
Non-GAAP Other income (expense), net $ (8,056) $ (38,393)
Appendix – reconciliation
Reconciliation of U.S. GAAP Other Income (Expense), Net to Non-GAAP Other Income (Expense), Net
(in thousands)
(unaudited)

-- 20 of 24 --

L A M R E S E A R C H
Confidential – Limited Access and Use
Three Months Ended
March 26,
2023
December 25,
2022
U.S. GAAP income before income taxes $ 938,922 $ 1,651,928
U.S. GAAP income tax expense $ 124,914 $ 183,421
U.S. GAAP income tax rate 13.3 % 11.1 %
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations - cost of goods sold $ 3,093 $ 2,521
Elective deferred compensation ("EDC") related liability valuation increase - cost of goods sold 1,498 2,853
Restructuring charges, net - cost of goods sold 66,720 —
Product rationalization - cost of goods sold 26,842 —
Transformational costs - cost of goods sold 558 —
EDC related liability valuation increase - research and development 2,697 5,136
Product rationalization - research and development 3,858 —
Amortization related to intangible assets acquired through certain business combinations - selling, general and administrative 1,395 1,279
EDC related liability valuation increase - selling, general and administrative 1,798 3,424
Product rationalization - selling, general and administrative 2,891 —
Transformational costs - selling, general and administrative 2,692 —
Restructuring charges, net – operating expenses 40,408 —
Amortization of note discounts - other income (expense), net 718 712
Gain on EDC related asset - other income (expense), net (5,443) (10,871)
Non-GAAP income before taxes $ 1,088,647 $ 1,656,982
Net income tax benefit on non-GAAP items $ 17,250 $ 1,213
Net income tax benefit associated with legal entity restructuring $ — $ 11,773
Non-GAAP income tax expense $ 142,164 $ 196,407
Non-GAAP income tax rate 13.1 % 11.9 %
Appendix – reconciliation
Reconciliation of U.S. GAAP Income Tax Rate to Non-GAAP Income Tax Rate
(in thousands, except percentages)
(unaudited)

-- 21 of 24 --

L A M R E S E A R C H
Confidential – Limited Access and Use
Three Months
Ended
March 26,
2023
U.S. GAAP net cash provided by operating activities $ 1,726,438
U.S. GAAP cash used for capital expenditures and intangible assets $ (119,457)
Total free cash flow $ 1,606,981
Appendix – reconciliation
Calculation of Free Cash Flows
(in thousands)
(unaudited)

-- 22 of 24 --

L A M R E S E A R C H
Confidential – Limited Access and Use
Reconciliation of U.S. GAAP to Non-GAAP Guidance for the
quarter ended June 25, 2023
The information provided above is only an estimate of what the Company believes is realizable as of the date of this release and does not incorporate the potential
impact of any business combinations, asset acquisitions, divestitures, restructuring, balance sheet valuation adjustments, financing arrangements, other investments,
or other significant arrangements that may be completed or recognized after the date of this release, except as described below. U.S. GAAP to non-GAAP reconciling
items provided include only those items that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations
may be material. Reconciling items included above are as follows:
• Gross margin as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $3 million; restructuring charges,
$20 million; product rationalization charges, $2 million; and transformational costs, $1 million, totaling $26 million.
• Operating income as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $4 million; restructuring
charges, $21 million; transformational costs, $9 million; and product rationalization charges, $2 million; totaling $36 million.
• Net income per diluted share - amortization related to intangible assets acquired though business combinations, $4 million; amortization of note discounts,
restructuring charges, $21 million; transformational costs, $9 million; product rationalization charges, $2 million; amortization of debt discounts, $1 million; and
associated tax benefit for non-GAAP items ($4 million); totaling $33 million.
U.S. GAAP Reconciling Items Non-GAAP
Revenue $3.1 Billion +/- $300 Million — $3.1 Billion +/- $300 Million
Gross margin as a percentage of revenue 43.2% +/- 1% $ 26 Million 44.0% +/- 1%
Operating income as a percentage of revenue 24.3% +/- 1% $ 36 Million 25.5% +/- 1%
Net income per diluted share $4.75 +/- $0.75 $ 33 Million $5.00 +/- $0.75
Diluted share count 134 million — 134 million
Appendix – reconciliation

-- 23 of 24 --



-- 24 of 24 --